Adamas Pharmaceuticals

Why Supernus' Acquisition of Adamas Is a Smart Move
Motley Fool
Thu, 10/21/21 - 09:30 am
Supernus
Adamas Pharmaceuticals
M&A
Parkinson's Disease
Supernus expands its portfolio of Parkinson's drugs with a $400M+ buyout
Endpoints
Mon, 10/11/21 - 10:08 am
Supernus
Parkinson's Disease
M&A
Adamas Pharmaceuticals
FDA Action Alert: Adamas, Mallinckrodt and Merck
BioSpace
Tue, 02/2/21 - 11:02 am
FDA
Adamas Pharmaceuticals
Mallinckrodt
Merck
Gocovri
StrataGraft
Keytruda
triple negative breast cancer
Mark Your Calendar For February PDUFA Dates
Yahoo/Benzinga
Sun, 01/31/21 - 10:18 pm
FDA
Adamas Pharmaceuticals
Gocovri
Mallinckrodt
StrataGraft
Regeneron
evinacumab
Sanofi
Sarepta
TG Therapeutics
Adamas Announces Positive Results from Ph III Study of Gocovri in Parkinson’s Patients with Dyskinesia
CP Wire
Thu, 04/19/18 - 11:46 pm
Adamas Pharmaceuticals
Gocovri
Parkinson's Disease
Adamas Announces Positive Results from Ph III Study of Gocovri in Parkinson’s Patients with Dyskinesia
Thu, 04/19/18 - 09:14 am
Adamas Pharmaceuticals
Gocovri
Parkinson's Disease
Parkinson's Now a Hot Therapeutic Area: What's Up Lately?
Yahoo/Zacks.com
Sat, 09/2/17 - 11:11 am
Parkinson's Disease
Novartis
Teva Pharmaceutial
UCB Pharma
MEDI1341
AstraZeneca
Takeda
PRX002
Prothena
Roche
Acorda
Inbrija
Adamas Pharmaceuticals
Gocovri
Adamas Parkinson's drug gains FDA approval
Biopharma Dive
Sat, 08/26/17 - 12:31 pm
Adamas Pharmaceuticals
Parkinson's Disease
FDA
Gocovri
Are These 2 Biotechs Diamonds in the Rough?
Motley Fool
Thu, 03/16/17 - 10:03 pm
biotech
Amicus Therapeutics
Adamas Pharmaceuticals
ADS-5102
Galafold
These 15 Biotech Companies Could Be Takeover Targets
Barron's
Wed, 06/29/16 - 12:56 pm
biotech
M&A
Alder Biopharmaceuticals
Biomarin
Coherus Biosciences
Intercept Pharma
Ultragenyx
Seattle Genetics
Adamas Pharmaceuticals
Alexion
Clovis Oncology
Corbus Pharmaceuticals
Incyte
Prothena
Puma Biotechnology
Tesaro
Versartis
Actavis, Adamas win FDA approval for Alzheimer's drug
Yahoo/Reuters
Wed, 12/24/14 - 08:54 am
Actavis
Adamas Pharmaceuticals
FDA
Alzheimer's disease
dementia
Namzaric
IPO Preview: Adamas Pharmaceuticals
Seeking Alpha
Thu, 04/10/14 - 07:45 am
IPOs
Adamas Pharmaceuticals
Forest Labs and Adamas Pharma sign agreement to develop dementia treatment
Equities.com
Sat, 12/15/12 - 01:03 pm
Adamas Pharmaceuticals
Alzheimer's disease
Forest Labs
Forest Inks Alzheimer's Drug Deal
Yahoo/Zacks
Fri, 11/16/12 - 10:58 am
Alzheimer's disease
Forest Labs
Namenda
Adamas Pharmaceuticals